BAI
vs
D
DAX Index
BAI
Over the past 12 months, BAI has underperformed DAX Index, delivering a return of 0% compared to the DAX Index's +5% growth.
Stocks Performance
BAI vs DAX Index
Performance Gap
BAI vs DAX Index
Performance By Year
BAI vs DAX Index
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
BenevolentAI SA
Glance View
BenevolentAI SA is a holding company that engages in the research and development and sale of AI-enabled drugs. The firm through the combined capabilities of its AI platform, scientific ability and wet-lab facilities deliver new drug candidates with a higher probability of clinical success than those developed using traditional methods. The company has an array of scientifically validated discoveries. The Company, through its BenevolentAI Platform, offers in-house pipeline of over 20 disease programs, spanning from target discovery to clinical studies, and it maintains commercial collaborations with pharmaceutical companies, such as AstraZeneca, as well as other research and charitable institutions.
